Related Experiment Video
Updated: May 3, 2026
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia
Leila N Varghese1, Jian-Guo Zhang, Samuel N Young
1The Walter and Eliza Hall Institute of Medical Research , Parkville, Victoria , Australia and.
Abstract:
Activation of the cell surface receptor, c-Mpl, by the cytokine, thrombopoietin (TPO), underpins megakaryocyte and platelet production in mammals. In humans, mutations in c-Mpl have been identified as the molecular basis of Congenital Amegakaryocytic Thrombocytopenia (CAMT). Here, we show that CAMT-associated mutations in c-Mpl principally lead to defective receptor presentation on the cell surface. In contrast, one CAMT mutant c-Mpl, F104S, was expressed on the cell surface, but showed defective TPO binding and receptor activation. Using mutational analyses, we examined which residues adjacent to F104 within the membrane-distal cytokine receptor homology module (CRM) of c-Mpl comprise the TPO-binding epitope, revealing residues within the predicted Domain 1 E-F and A-B loops and Domain 2 F'-G' loop as key TPO-binding determinants. These studies underscore the importance of the c-Mpl membrane-distal CRM to TPO-binding and suggest that mutations within this CRM that perturb TPO binding could give rise to CAMT.
Insights
Mutations in c-Mpl cause Congenital Amegakaryocytic Thrombocytopenia (CAMT) by affecting cell surface presentation or thrombopoietin (TPO) binding. Key TPO-binding sites in c-Mpl's CRM domain were identified.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Thrombopoietin (TPO) activates the c-Mpl receptor, essential for megakaryocyte and platelet production.
- Mutations in c-Mpl are the primary cause of Congenital Amegakaryocytic Thrombocytopenia (CAMT) in humans.
Purpose of the Study:
- To investigate the molecular mechanisms by which CAMT-associated c-Mpl mutations lead to thrombocytopenia.
- To identify the TPO-binding epitope on the c-Mpl receptor.
Main Methods:
- Analysis of CAMT-associated c-Mpl mutants for cell surface expression and TPO binding.
- Site-directed mutagenesis to probe TPO-binding residues within the c-Mpl membrane-distal cytokine receptor homology module (CRM).
Main Results:
- Most CAMT mutations impair c-Mpl cell surface presentation.
- The F104S CAMT mutant exhibits normal surface expression but defective TPO binding and activation.
- Specific residues in Domain 1 (E-F, A-B loops) and Domain 2 (F'-G' loop) of the c-Mpl CRM are critical for TPO binding.
Conclusions:
- Defective c-Mpl presentation or impaired TPO binding due to mutations can cause CAMT.
- The membrane-distal CRM of c-Mpl is crucial for TPO recognition and receptor activation.
Related Concept Videos
01:27Cytomegalovirus Disease
01:39Mutations